To examine next-day cognitive performance and subjective drug effects after smoking cannabis and to assess associations between performance and cannabinoid c…
Medical Cannabis and Palliative Care: What This End-of-Life Study Actually Shows
CED Clinical Relevance #88 High Clinical Relevance This paper addresses a clinically important real-world question at end of life, but the design only supports cautious, association-level interpretation. 📋 Clinical Insight | CED...
Acute toxicity of ADB-CHMINACA – a case series of patients with pronounced central nervous symptoms including the posterior reversible encephalopathic syndrome.
This report presents a series of 16 patients who were admitted to the emergency department following confirmed intake of the potent synthetic cannabinoid ADB…
Medicinal Cannabis Prescription Before an Inpatient Psychiatric Admission: A Retrospective Observational Audit.
Prescribing of medicinal cannabis has expanded in Australia; however, evidence for benefit in psychiatric populations is limited. The goal of this study was …
Substance use in supportive oncology and its impact on clinical outcomes and care.
Substance use spans a continuum from occasional use to hazardous use and clinically defined substance use disorders, and it can shape outcomes across the can…
Older Adults Using Prescribed Cannabis Report Well-Being Improvements, But Causal Claims Remain Unsupported
Older aged individuals experience considerable improvement in health and well-being when prescribed cannabis-based medicinal products—though this is an observational registry without a control group, so causality cannot be established.
Cannabis Use Linked to Higher Blood Clot Risk in Older Trauma Patients
THC+ patients had significantly higher rates of TEC compared to THC- patients (3.0% vs. 1.7%; p=0.01). Rates of DVT (2.2% vs 0.6%, p<0.01) and PE (1.4% vs 0.4%, p<0.01) were higher in the THC+ group.
Older Adults on Prescribed Cannabis Report Well-Being Gains, But Study Cannot Rule Out Placebo or Natural Recovery
Older aged individuals experience considerable improvement in health and well-being when prescribed cannabis-based medicinal products — though these findings come from an observational registry without a comparator arm, meaning improvement cannot be attributed solely to the intervention.
Older Adults Prescribed Cannabis in UK Show Self-Reported Well-Being Gains, But Study Design Cannot Confirm Treatment Caused Improvement
Older aged individuals experience considerable improvement in health and well-being when prescribed cannabis-based medicinal products—though the study design, lacking a comparator group, cannot exclude placebo response, regression to the mean, or natural disease course as explanations.
Cannabis Positive Drug Screen Linked to Higher Blood Clot Risk in Older Trauma Patients
THC+ patients had significantly higher rates of TEC compared to THC- patients (3.0% vs. 1.7%; p=0.01). Rates of DVT (2.2% vs 0.6%, p<0.01) and PE (1.4% vs 0.4%, p<0.01) were higher in the THC+ group.